Morgan Stanley’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1B | Sell |
4,625,329
-328,999
| -7% | -$68.4M | 0.06% | 288 |
|
|
2026
Q1 | $1.05B | Sell |
4,954,328
-168,360
| -3% | -$36.3M | 0.06% | 274 |
|
|
2025
Q4 | $1.05B | Sell |
5,122,688
-107,629
| -2% | -$20.3M | 0.06% | 273 |
|
|
2025
Q3 | $821M | Sell |
5,230,317
-243,154
| -4% | -$37.6M | 0.05% | 354 |
|
|
2025
Q2 | $920M | Buy |
5,473,471
+566,837
| +12% | +$84.1M | 0.06% | 297 |
|
|
2025
Q1 | $676M | Sell |
4,906,634
-172,591
| -3% | -$22M | 0.05% | 368 |
|
|
2024
Q4 | $601M | Buy |
5,079,225
+131,515
| +3% | +$15.4M | 0.04% | 416 |
|
|
2024
Q3 | $547M | Buy |
4,947,710
+193,512
| +4% | +$20.2M | 0.04% | 435 |
|
|
2024
Q2 | $467M | Buy |
4,754,198
+388,120
| +9% | +$39.5M | 0.04% | 470 |
|
|
2024
Q1 | $489M | Sell |
4,366,078
-127,791
| -3% | -$13.8M | 0.04% | 449 |
|
|
2023
Q4 | $453M | Buy |
4,493,869
+77,385
| +2% | +$7.68M | 0.04% | 435 |
|
|
2023
Q3 | $383M | Sell |
4,416,484
-286,373
| -6% | -$25.9M | 0.04% | 456 |
|
|
2023
Q2 | $445M | Sell |
4,702,857
-735,233
| -14% | -$62.1M | 0.04% | 408 |
|
|
2023
Q1 | $411M | Buy |
5,438,090
+843,906
| +18% | +$63.7M | 0.04% | 418 |
|
|
2022
Q4 | $353M | Buy |
4,594,184
+161,667
| +4% | +$12.3M | 0.04% | 459 |
|
|
2022
Q3 | $296M | Buy |
4,432,517
+121,598
| +3% | +$7.71M | 0.04% | 442 |
|
|
2022
Q2 | $225M | Buy |
4,310,919
+2,104,125
| +95% | +$120M | 0.03% | 542 |
|
|
2022
Q1 | $125M | Buy |
2,206,794
+98,820
| +5% | +$5.29M | 0.02% | 738 |
|
|
2021
Q4 | $109M | Sell |
2,107,974
-50,548
| -2% | -$2.48M | 0.01% | 848 |
|
|
2021
Q3 | $107M | Buy |
2,158,522
+138,315
| +7% | +$7.5M | 0.01% | 809 |
|
|
2021
Q2 | $115M | Buy |
2,020,207
+643,723
| +47% | +$37.6M | 0.02% | 778 |
|
|
2021
Q1 | $83.6M | Sell |
1,376,484
-6,363
| -0.5% | -$351K | 0.01% | 861 |
|
|
2020
Q4 | $74.1M | Buy |
1,382,847
+177,823
| +15% | +$9.23M | 0.01% | 855 |
|
|
2020
Q3 | $56.6M | Buy |
1,205,024
+150,746
| +14% | +$7.74M | 0.01% | 845 |
|
|
2020
Q2 | $55M | Sell |
1,054,278
-11,637
| -1% | -$600K | 0.01% | 798 |
|
|
2020
Q1 | $51.1M | Sell |
1,065,915
-375,313
| -26% | -$19.5M | 0.01% | 732 |
|
|
2019
Q4 | $72.9M | Buy |
1,441,228
+181,552
| +14% | +$9.38M | 0.02% | 746 |
|
|
2019
Q3 | $59.4M | Buy |
1,259,676
+423,672
| +51% | +$19.3M | 0.02% | 770 |
|
|
2019
Q2 | $39.4M | Sell |
836,004
-739,322
| -47% | -$34.1M | 0.01% | 987 |
|
|
2019
Q1 | $75.9M | Buy |
1,575,326
+178,414
| +13% | +$8.94M | 0.02% | 642 |
|
|
2018
Q4 | $62.3M | Buy |
1,396,912
+264,282
| +23% | +$13.8M | 0.02% | 722 |
|
|
2018
Q3 | $61.2M | Sell |
1,132,630
-400,670
| -26% | -$20.5M | 0.02% | 830 |
|
|
2018
Q2 | $74.9M | Buy |
1,533,300
+467,818
| +44% | +$26.5M | 0.02% | 717 |
|
|
2018
Q1 | $66.8M | Sell |
1,065,482
-462,216
| -30% | -$31.7M | 0.02% | 769 |
|
|
2017
Q4 | $93.6M | Sell |
1,527,698
-113,478
| -7% | -$7.02M | 0.03% | 621 |
|
|
2017
Q3 | $110M | Buy |
1,641,176
+711,351
| +77% | +$50.3M | 0.03% | 522 |
|
|
2017
Q2 | $72.5M | Sell |
929,825
-1,105,514
| -54% | -$83.4M | 0.02% | 717 |
|
|
2017
Q1 | $166M | Buy |
2,035,339
+402,151
| +25% | +$31.7M | 0.05% | 375 |
|
|
2016
Q4 | $118M | Buy |
1,633,188
+416,650
| +34% | +$30.1M | 0.04% | 469 |
|
|
2016
Q3 | $94.5M | Sell |
1,216,538
-375,541
| -24% | -$30.3M | 0.03% | 548 |
|
|
2016
Q2 | $124M | Sell |
1,592,079
-252,820
| -14% | -$20.2M | 0.04% | 443 |
|
|
2016
Q1 | $151M | Buy |
1,844,899
+92,055
| +5% | +$7.48M | 0.06% | 353 |
|
|
2015
Q4 | $156M | Buy |
1,752,844
+191,945
| +12% | +$16.3M | 0.06% | 350 |
|
|
2015
Q3 | $120M | Sell |
1,560,899
-309,441
| -17% | -$25.9M | 0.04% | 414 |
|
|
2015
Q2 | $156M | Buy |
1,870,340
+259,828
| +16% | +$22.9M | 0.05% | 375 |
|
|
2015
Q1 | $145M | Sell |
1,610,512
-402,456
| -20% | -$34.6M | 0.05% | 376 |
|
|
2014
Q4 | $163M | Buy |
2,012,968
+629,205
| +45% | +$49.7M | 0.06% | 354 |
|
|
2014
Q3 | $104M | Sell |
1,383,763
-120,950
| -8% | -$8.8M | 0.04% | 504 |
|
|
2014
Q2 | $103M | Sell |
1,504,713
-471,258
| -24% | -$32.1M | 0.04% | 504 |
|
|
2014
Q1 | $138M | Sell |
1,975,971
-156,115
| -7% | -$10.9M | 0.06% | 366 |
|
|
2013
Q4 | $142M | Buy |
2,132,086
+264,685
| +14% | +$16.2M | 0.06% | 349 |
|
|
2013
Q3 | $97.4M | Buy |
1,867,401
+164,915
| +10% | +$8.38M | 0.05% | 427 |
|
|
2013
Q2 | $80.4M | Buy |
+1,702,486
| New | +$77.8M | 0.04% | 461 |
|
Other funds holding CAH
Morgan Stanley's CAH Position: Q2 2026 in Review
Morgan Stanley reduced its Cardinal Health (CAH) stake by 6.6% in Q2 2026, selling an estimated $68.4M and leaving 4,625,329 shares worth $1.1B. The position accounts for 0.06% of the portfolio, ranked #288.
Morgan Stanley first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Morgan Stanley held 4,625,329 shares of Cardinal Health worth $1.1B as of Q2 2026.
- Morgan Stanley sold 328,999 Cardinal Health shares in Q2 2026, an estimated $68.4M.
- Cardinal Health made up 0.06% of Morgan Stanley's portfolio in Q2 2026, its #288 holding.
- Morgan Stanley first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.